[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
January 22, 1997

The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)

Author Affiliations

University of Tennessee, Memphis
Bowman Gray School of Medicine Winston-Salem, NC
Shapiro Center Minneapolis, Minn

JAMA. 1997;277(4):297. doi:10.1001/jama.1997.03540280035025

To the Editor.  —The undersigned authors participated in the conduct of MIDAS.1 For the record, we feel it important to state publicly why we dropped out of the investigative group while the final paper was under preparation. At the point of our departure, we believed that the sponsor of the study was attempting to wield undue influence on the nature of the final paper. This effort was so oppressive that we felt it inhibited academic freedom and led to substantial differences within the MIDAS group with regard to the ultimate presentation and interpretation of the results.Fortunately, the published article is very near to the paper we would have written had we remained part of the investigative group. We congratulate the authors on the final product and wish to express our respect for the peer review process that helped lead to an improved publication.